Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2024 Jun 11;19(6):e0304172. doi: 10.1371/journal.pone.0304172

Alternative method to visualize receptor dynamics in cell membranes

Ravelli Cosetta 1,2,*, Corsini Michela 1,2, Ventura Anna 1, Domenichini Mattia 1, Grillo Elisabetta 1,2, Mitola Stefania 1,2,*
Editor: Eleftherios Paschalis Ilios3
PMCID: PMC11166301  PMID: 38861534

Abstract

There is a close relation between membrane receptor dynamics and their behavior. Several microscopy techniques have been developed to study protein dynamics in live cells such as the Fluorescence Recovery After Photobleaching (FRAP) or the Single Particle Tracking (SPT). These methodologies require expensive instruments, are time consuming, allow the analysis of small portion of the cell or an extremely small number of receptors at a time. Here we propose a time-saving approach that allows to visualize the entire receptor pool and its localization in time. This protocol requires an epifluorescence microscope equipped for structured illuminated sectioning and for live cell imaging. It can be applied to characterize membrane receptor and multi protein complex and their response to activators or inhibitors. Image acquisition and analysis can be performed in two days, while cells and substratum preparation require a few minutes a day for three days.

Introduction

Cell surface transmembrane receptors transduce extracellular cues into intracellular signaling. These proteins can be either associated to or integrated into the cell membrane. Membrane receptors are mainly divided into 3 classes: the ion channel receptors which are multi-pass transmembrane proteins, the G protein anchored receptors with seven transmembrane helices and the enzyme-linked receptors with a single-pass transmembrane helix. Among the later the Tyrosine Kinase Receptors (RTKs) play important roles in the regulation of cell growth, differentiation, and survival. They bind and respond to growth factors and other locally released proteins that are present at low concentrations. Upon the interaction with their specific ligand, RTKs dimerize with neighboring receptors and trans-phosphorylate their cytoplasmic tails which serve as docking sites for various intracellular proteins involved in signal transduction. Although several RTK ligands are soluble molecules, in tissues these are often associated with different extracellular matrix (ECM) components, including heparan-sulfate proteoglycans (HSPGs), leading to the formation of immobilized ECM-bound complexes. Several evidence shows that angiogenic growth factors, including VEGFs, can be found associated with endothelial ECM in vitro and with blood vessel basement membranes in vivo [1, 2].

The plasma membrane closed in contact with ECM was formally considered a 2D solution in which proteins and lipoproteins represented the solute dissolved in a viscous solvent consisting of phospholipids forming the so called “fluid mosaic” [3]. Thus, plasma membrane can be considered as a semipermeable barrier at the interface with tissue microenvironment. Membrane has a thickness of 5–10 nm consisting of a phospholipid bilayer enriched with lipids, proteins, and sugars. Most of the membrane activities are carried out by membrane proteins which can be integral, peripheral, or surface associated. In contrast with the initial assumption, it is well known now that the plasma membranes do not have a homogeneous composition and that proteins, as well as lipids, tend to concentrate in particular areas, giving rise to different membrane domains that perform different biological activities, e.g. lipid rafts, caveolae and focal adhesions [4]. Membrane proteins and lipids, as well as cortical actin (the cytoskeleton in direct contact with the plasma membrane) influence the formation and the remodeling of these membrane domains, finally defining their function and cell response to external stimuli [5]. These membrane structures govern the dynamics of proteins in the plasma membrane and their availability for ligands, co-receptors, and intracellular scaffolds. We can described the lateral regulation of RTK dynamics as a fine regulatory ways to modulate the cell/environment interactions [6, 7]. The relocation of RTKs in membrane domains is facilitated by the membrane fluidity. For example, in endothelium the spatial regulation of RTK also influences the fate and polarity of cells. Indeed, receptor localization defines the apical, the apical-lateral and the basal portion of the plasma membrane and their functions. The cell basal portion has been mainly studied for its interactions with the basal lamina, the apical lateral modulates the intravasation and extravasation fluxes and the apical portion is exposed to blood flow. In blood vessels, for example, the podocalyxin, VE-Cadherin and β1 integrin respectively characterize the different cell portions while the localization of other proteins (e.g. growth factor receptors) are non-restricted and they freely relocalize regulating different biological aspects [2, 8, 9].

The Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) is recruited at the leading edge in growing blood vessels while it relocalizes in the cell junction just in contact with VE-Cadherin or at the basal contact. We recently showed that VEGF- or gremlin-enriched matrix triggers a rapid relocation and long-term activation of VEGFR2 at the basal aspect of motile endothelium [2, 10]. The different receptor localization also determines its bioavailability for extracellular ligands or drugs. It therefore becomes important to be able to analyze the dynamic capacity of the receptors and their localization. The analysis of receptor dynamics in live cells can be achieved through different microscopy-based assays, including Fluorescence recovery after photobleaching (FRAP) [10, 11] and Single particle tracking (SPT) [12, 13], that allow following respectively the collective or single molecule dynamics of RTKs. These assays need a Laser Scanning Confocal (LSC) or a Total Internal Reflection Fluorescence (TIRF) microscopy, to photo-bleach a membrane area or to analyze only the portion of membrane in close contact with the coverglass, respectively.

Here we propose an economic and easy assay to follow and characterize the membrane receptor dynamics using an epifluorescent microscopy (Fig 1). Briefly, fluorescent–tagged receptor expressing cells were cultured on coverglass and, at the time of observation, coverglass was flipped on ligand-adsorbed coverglass mimicking the first step of migration process (Fig 2). Under this experimental condition, receptors are recruited in the area close in contact with their ligands while cells progressively attach to the new substrate. Similar to migrating cell, adherent cell tests the microenvironment, reorganize the adhesion contacts, move to the new substrate and detach from the previous sites.

Fig 1. Experimental flow chart.

Fig 1

Fig 2. Cartoon of steps 3–5 of experimental flow chat.

Fig 2

Materials and methods

Step by step protocol is included in Protocol.io (DOI: dx.doi.org/10.17504/protocols.io.rm7vzj8z8lx1/v1).

The primary aim of this study was to establish a new, cheap, and easy method to study receptor dynamics on plasma membranes. Unlike other methods, this protocol allows to follow in time the reorganization of the receptor using an epifluorescence microscope equipped with a structured illumination system. The experiments are conducted with cells stably expressing receptors tagged with fluorescent proteins. The transient transfection of cells allows, in the case of VEGFR2, to increase the receptor expression exposed on the plasma membrane.

Materials

  1. Pre-cleaned round borosilicate coverslips (12 mm diameter; 0.1 mm thickness) (Menzel Glaser, #CB00120RA120).

  2. 6 well and 24 well cell culture plate (Corning, #3516).

  3. Needle.

  4. Tweezers.

  5. 2-wells chambered coverslips for use in immunofluorescence and high-end microscopy (0.15mm thickness) (IBIDI, #80286).

  6. Chinese Hamster Ovary (CHO) cells (ATCC, https://web.expasy.org/cellosaurus/CVCL_0213) or other adherent cells.

  7. Polyethylenimine (PEI) (MERCK, 764965).

  8. HAM’sF12 medium (Gibco, #11550043), eventually supplemented with (10U/mL) Penicillin-streptomycin (Gibco, #15140122) and 10% or 1% fetal calf serum (FCS).

  9. pBE-hVEGFR2-eYFP, kindly provided by Dr. Kalina Hristova, Johns Hopkins University, Baltimore, USA.

  10. PBS for cell culture (Gibco, #10010023).

  11. Bovine Serum Albumin (BSA) (Thermofisher #15561020).

  12. Recombinant VEGF-A165 (R&D system, #293-VE-010/CF).

Equipment

● Cell culture incubator.

  • Epifluorescence microscope equipped with structured illumination system for optical sectioning, a high magnification and high-resolution objective, incubation system and a monochrome camera (Axio Observer equipped with Apotome 3, Axiocam 305 mono and Plan-Apochromat 63X/1.4 Oil; Zeiss Italia SPA).

  • Fiji software (https://imagej.net/software/fiji/).

Expected results

Here we used the vascular endothelial growth factor receptor 2 (VEGFR2), a typical tyrosine kinase receptor, to set up a method to easily follow and quantify the relocation of the membrane receptor upon extracellular ligand stimulation using epifluorescence microscopy paired with structured illumination sectioning. As extracellular ligand and stimulus we used VEGF-A 165 which binds VEGFR2 with high affinity. Although the VEGF family members are considered soluble molecules, many isoforms contain heparin binding domains and in tissues are therefore bound to the heparan sulfates of the extracellular matrix (ECM). So, to mimic what happens in vivo we followed the dynamics of VEGFR2 in pre-seeded CHO cells stimulated with immobilized VEGF-A 165. Cells transfected with a pBE plasmid encoding hVEGFR2-EYFP, were completely attached before their interaction with VEGF-A-enriched ECM. Indeed, cells were cultured for 24 hours on coverslip in complete growth medium. Under this culture condition, VEGFR2 was positioned in its physiological location maintaining its dynamics. The coverslip with cells were placed, face down, on a chamber slide pre-coated with VEGF-A 165 and incubated in an incubator on the microscope (Fig 2).

A hair was used as a spacer between the two glasses to avoid cell crushing. The cells quickly reacted to the stimulus and polarized, directing the receptor towards the ligands and attached to it. The reorganization of VEGFR2 on the cell membrane was analyzed by acquiring Z-stack images of the cell at different times (from 5 to 120 minutes). Orthogonal projection showed that all VEGFR2-EYFP were expressed on cell membranes (Fig 3A and dx.doi.org/10.17504/protocols.io.rm7vzj8z8lx1/v1).

Fig 3. Orthogonal projection of VEGFR2-EYFP expressing CHO cells adhering to VEGF-A and fluorescence quantification.

Fig 3

(A) Image of the apical stack and the X and Y projection of total Z-stack of cells 5 and 120 minutes after ligand interaction. (B) Darkening purple curves represent the distribution of normalized fluorescence intensity (%) in stacks during time (5, 10, 30, 60 and 120 minutes). Images are representative of 3 independent experiments that gave similar results. Data were obtained from 20 cells for each time point in 3 independent experiments.

The time series of orthogonal projections showed the evolution over time of the reorganization of VEGFR2 on the cell that, sensing the stimulus of VEGF-A, organized itself to adhere to the new substrate. The Z-stack reconstruction clearly showed that VEGFR2 moved towards the immobilized VEGF-A until the cell completely adhered to the stimulus. At 120 minutes, the cells completely detached from the slide to which they were previously attached to move towards the stimulus (Fig 3A). To calculate the percentage of receptor recruited in close contact to growth factors, fluorescence-positive areas of each Z-stack section were quantified using Fiji following instructions detailed in step 5 of the step-by-step protocol described in (DOI: dx.doi.org/10.17504/protocols.io.rm7vzj8z8lx1/v1). By analyzing single stacks with Fiji, distribution curves of VEGFR2 at different times were also constructed. Fig 3B shows the percentage of VEGFR2 in Z stacks starting from 5 up to 120 minutes. The passage of time is represented by the darkening of the purple curves. At 5 minutes, the receptor appears to be uniformly distributed, with a small amount in the apical portion of the cell, due to the shape of the cell. It is possible to appreciate a progressive bending of the curves towards the first Z stack which is the closest to VEGF. This demonstrates that VEGFR2 is able to polarize when stimulated by an immobilized ligand. The increasing amount of VEGFR2-EYFP in close contact with immobilized VEGF can be visualized using the 3D reconstruction with depth coding option. The entire thickness of 13 μm was represented with a color coding in which blue is the starting coverslip and red the immobilized VEGF. The red color increased with the adhesion and after 120 minutes of adhesion red color was preponderant compared to blue (Fig 4A). The recruited receptor was quantified in stacks close to VEGF (Fig 4B).

Fig 4. 3D reconstruction of EYFP-VEGFR2 recruitment in CHO.

Fig 4

(A) Depth coding of 3D reconstruction of EYFP-VEGFR2. Red color represents the portion of the cell in close contact with immobilized VEGF while blue color represents the portion of the cell detaching from the coverslip. (B) Quantification in time of VEGFR2 recruitment in the basal portion of the cell. Images are representative of 3 independent experiments that gave similar results. Data were obtained from 20 cells for each time point in 3 independent experiments.

This assay represents an easy method to analyze the relocation and protein diffusion on cell membranes. This represents an alternative method to FRAP and to SPT. All of these are fluorescent-based methods, but they need respectively an epifluorescence, a confocal and a total internal reflection fluorescence (TIRF) microscope. Similar to the method described above FRAP, using a laser scan, measures the average diffusion characteristics of molecules. Both techniques are an averaging method, i.e. the data derive from the average behavior of several fluorescent molecules over time and space. Although FRAP is a sensitive method, it is not free from important technical limits: first, the high intensity lighting used to extinguish the fluorescence can induce photo-damaging effects of the cell. This can be overcome using epifluorescence microscopy in which the lamp is less energetic than a laser. To finely characterize the trajectory of the molecule the SPT is a very useful method. Although SPT gives more information, it is an extremely time-consuming technique (Table 1).

Table 1. Advantages and disadvantages of microscopy techniques for the study of molecule dynamics.

Microscopy techniques Advantages Disadvantages
Whole cell 4D fluorescence reconstruction Cheap; Bulk visualization;
Whole-cell visualization; Need of structured illumination microscopy or image deconvolution.
Chance to follow receptor internalization.
Fluorescence Recovery After Photobleaching (FRAP) Fast identification of mobile and immobile molecular fractions; Characterization of a restricted area of the cell;
Easy definition of Diffusion Coefficient. Photodamage;
Need of Confocal Laser Scanning Microscopy (CLSM).
Single Particle Tracking (SPT) Visualize the position of single molecule and record its trajectories; Need of Total Internal Reflection Fluorescence (TIRF) microscopy;
High temporal and spatial resolution Large amount of data to analyze.

Of note, the acquisition and image reconstruction can also be performed with a laser scan confocal microscope, even if more time consuming. Acquiring images with a camera allows the analysis of more than one cell at a time in Z-stack and time lapse. Also, at the end of analysis cells can be fixed and immunostained. The increased membrane area and its close contact with coverslip facilitates the analysis and the quantification of the positive area [14, 15] and eventually allows to perform FRET analysis. In FRAP experiments the receptor dynamics can be observed in all membrane areas which are extremely plastic upon stimulation, while in SPT the time of analysis is extremely shorter.

We believe that this method is easily achievable in many basic laboratories and can provide guidance in a relatively short time. The recruitment assay will be useful to characterize not only the ligand-receptor interactions increasing the area of observation and make easier the study the direct interaction but also can be used to visualize the formation of multi receptors complex in cell membrane or to the recruitment of intracellular mediators. We showed that the recruitment of VEGFR2 by gremlin is followed by the recruitment of β3 integrin, which forms an active complex with VEGFR2, and of PI 3-kinase p85 subunit [2]. The method can be used with different types of adherent cells, including GM7373 and human umbilical vascular endothelial cells (HUVECs), different stimuli [10] and following not only VEGFR2 but also other types of receptors (e.g. β3 integrin) [2]. As an alternative to fluorescent protein-tagged receptors, a 4’phosphopantetheinyl transferase (PPTase)-based labeling can be used to label S6-Tag receptors specifically exposed on membrane and visualize their membrane dynamics and eventually their internalization [12]. While in the previous studies we quantified only the amount of receptor reaching the substratum, here we describe the quantification of the distribution of the entire pool of receptors in the cell in time.

Supporting information

S1 File

(PDF)

pone.0304172.s001.pdf (263.7KB, pdf)

Acknowledgments

The authors performed experiments at the Imaging Platform at DMMT, University of Brescia.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

This work was supported by grants from Associazione Italiana per la Ricerca sul Cancro (AIRC) to S.M. (IG 2021 Id25726), from MIUR to Consorzio Interuniversitario di Biotecnologie (CIB) to C.R., E.G., and S.M.; from “PNRR M4C2-Investimento 1.4-CN00000041 finanziato dall’Unione Europea–NextGenerationEU” to S.M and M.C. “The Mechanobiology Research Center” was supported by liberal donations of Copan and Antares Vision. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Rusnati M, Presta M (2006) Extracellular angiogenic growth factor interactions: an angiogenesis interactome survey. Endothelium: journal of endothelial cell research 13 (2):93–111. doi: 10.1080/10623320600698011 [DOI] [PubMed] [Google Scholar]
  • 2.Ravelli C, Grillo E, Corsini M, Coltrini D, Presta M, Mitola S (2015) beta3 Integrin Promotes Long-Lasting Activation and Polarization of Vascular Endothelial Growth Factor Receptor 2 by Immobilized Ligand. Arteriosclerosis, thrombosis, and vascular biology 35 (10):2161–2171. doi: 10.1161/ATVBAHA.115.306230 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Singer SJ, Nicolson GL (1972) The fluid mosaic model of the structure of cell membranes. Science 175 (4023):720–731. doi: 10.1126/science.175.4023.720 [DOI] [PubMed] [Google Scholar]
  • 4.46th ESAO Congress 3–7 September 2019 Hannover, Germany Abstracts (2019). Int J Artif Organs 42 (8):386–474. doi: 10.1177/0391398819860985 [DOI]
  • 5.Svitkina TM (2020) Actin Cell Cortex: Structure and Molecular Organization. Trends in cell biology 30 (7):556–565. doi: 10.1016/j.tcb.2020.03.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Jaqaman K, Kuwata H, Touret N, Collins R, Trimble WS, Danuser G, et al. (2011) Cytoskeletal control of CD36 diffusion promotes its receptor and signaling function. Cell 146 (4):593–606. doi: 10.1016/j.cell.2011.06.049 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Kuwata H (2012) [Cytoskeletal control of CD36 diffusion promotes its receptor and signaling function in human primary macrophage]. Seikagaku The Journal of Japanese Biochemical Society 84 (12):1012–1016. [PubMed] [Google Scholar]
  • 8.Bussolino F, Serini G, Mitola S, Bazzoni G, Dejana E (2001) Dynamic modules and heterogeneity of function: a lesson from tyrosine kinase receptors in endothelial cells. EMBO reports 2 (9):763–767. doi: 10.1093/embo-reports/kve181 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Lampugnani MG, Orsenigo F, Gagliani MC, Tacchetti C, Dejana E (2006) Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments. The Journal of cell biology 174 (4):593–604. doi: 10.1083/jcb.200602080 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Damioli V, Salvadori A, Beretta GP, Ravelli C, Mitola S (2017) Multi-physics interactions drive VEGFR2 relocation on endothelial cells. Scientific reports 7 (1):16700. doi: 10.1038/s41598-017-16786-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Grillo E, Corsini M, Ravelli C, di Somma M, Zammataro L, Monti E, et al. (2021) A novel variant of VEGFR2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasis. Cancer letters 496:84–92. doi: 10.1016/j.canlet.2020.09.027 [DOI] [PubMed] [Google Scholar]
  • 12.Amodeo R, Convertino D, Calvello M, Ceccarelli L, Bonsignore F, Ravelli C, et al. (2020) Fluorolabeling of the PPTase-Related Chemical Tags: Comparative Study of Different Membrane Receptors and Different Fluorophores in the Labeling Reactions. Frontiers in molecular biosciences 7:195. doi: 10.3389/fmolb.2020.00195 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Amodeo R, Nifosi R, Giacomelli C, Ravelli C, La Rosa L, Callegari A, et al. (2020) Molecular insight on the altered membrane trafficking of TrkA kinase dead mutants. Biochimica et biophysica acta Molecular cell research 1867 (2):118614. doi: 10.1016/j.bbamcr.2019.118614 [DOI] [PubMed] [Google Scholar]
  • 14.Chiodelli P, Mitola S, Ravelli C, Oreste P, Rusnati M, Presta M (2011) Heparan sulfate proteoglycans mediate the angiogenic activity of the vascular endothelial growth factor receptor-2 agonist gremlin. Arteriosclerosis, thrombosis, and vascular biology 31 (12):e116–127. doi: 10.1161/ATVBAHA.111.235184 [DOI] [PubMed] [Google Scholar]
  • 15.Rezzola S, Di Somma M, Corsini M, Leali D, Ravelli C, Polli VAB, et al. (2019) VEGFR2 activation mediates the pro-angiogenic activity of BMP4. Angiogenesis. doi: 10.1007/s10456-019-09676-y [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Eleftherios Paschalis Ilios

3 Apr 2024

PONE-D-24-04439Alternative method to visualize receptor dynamics in cell membranes.PLOS ONE

Dear Dr. Mitola,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by May 18 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Eleftherios Paschalis Ilios

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include a link to the protocols.io entry in your Methods section.

3. We note you have not yet provided a protocols.io PDF version of your protocol and/or a protocols.io DOI. When you submit your revision, please provide a PDF version of your protocol as generated by protocols.io (the file will have the protocols.io logo in the upper right corner of the first page) as a Supporting Information file. The filename should be S1_file.pdf, and you should enter “S1 File” into the Description field. Any additional protocols should be numbered S2, S3, and so on. Please also follow the instructions for Supporting Information captions [https://journals.plos.org/plosone/s/supporting-information#loc-captions]. The title in the caption should read: “Step-by-step protocol, also available on protocols.io.”

Please assign your protocol a protocols.io DOI, if you have not already done so, and include the following line in the Materials and Methods section of your manuscript: “The protocol described in this peer-reviewed article is published on protocols.io (https://dx.doi.org/10.17504/protocols.io.[...]) and is included for printing purposes as S1 File.” You should also supply the DOI in the Protocols.io DOI field of the submission form when you submit your revision.

If you have not yet uploaded your protocol to protocols.io, you are invited to use the platform’s protocol entry service [https://www.protocols.io/we-enter-protocols] for doing so, at no charge. Through this service, the team at protocols.io will enter your protocol for you and format it in a way that takes advantage of the platform’s features. When submitting your protocol to the protocol entry service please include the customer code PLOS2022 in the Note field and indicate that your protocol is associated with a PLOS ONE Lab Protocol Submission. You should also include the title and manuscript number of your PLOS ONE submission.

4. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. 

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

5. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process.

6. Please ensure that you refer to Figure 1 in your text as, if accepted, production will need this reference to link the reader to the figure.

7. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

Additional Editor Comments:

The two reviewers made valid comments which need to be addressed before this paper is considered further. Please review the comments and address them to the best of your ability.

Thank you

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript report a protocol which is of utility to the research community and adds value to the published literature?

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the protocol been described in sufficient detail?

To answer this question, please click the link to protocols.io in the Materials and Methods section of the manuscript (if a link has been provided) or consult the step-by-step protocol in the Supporting Information files.

The step-by-step protocol should contain sufficient detail for another researcher to be able to reproduce all experiments and analyses.

Reviewer #1: Partly

Reviewer #2: Yes

**********

3. Does the protocol describe a validated method?

The manuscript must demonstrate that the protocol achieves its intended purpose: either by containing appropriate validation data, or referencing at least one original research article in which the protocol was used to generate data.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. If the manuscript contains new data, have the authors made this data fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: N/A

Reviewer #2: Yes

**********

5. Is the article presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please highlight any specific errors that need correcting in the box below.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The proposed manuscript by R. Cosetta and al. is dedicated to the development of a new approach to determine the receptor dynamics in the cell membrane. This approach was developed to use technology easily available in most research centers. This technological manuscript well describes the interest of such approach. However, some important points should be addressed to improve this manuscript:

- The authors indicated that this approach was "...an economical and simple assay to follow and characterize membrane receptor dynamics..." and that the use of epifluorescence microscopy (EM) was possible. However, in their descriptions, the authors used confocal microscopy and some related techniques such as image stacking (not really accessible in EM). The authors should describe the use of EM in this approach.

- The number of cells analyzed was not reported. The number of experiments was also not reported. These items should be reported.

- How was the percentage of positive areas determined? Image analysis ? Software used ? procedure ?

- The authors do not discuss other methods to study receptor dynamics. This should be discussed. The advantages and limitations of this new approach should also be discussed.

- The authors cited reference 17 for analysis of VEGFR and other receptor expression, but this reference did not use the same method. This should be discussed.

- The authors do not indicate whether the internalization of the receptors could be detected with this method ? or not.

Reviewer #2: The authors provide an alternative cost effective method for visualizing receptor dynamics in cell membranes.The protocol is well-described, providing clear step-by-step instructions for conducting the experiments. There are few suggestions that would help to improve the manuscript:

1. The introduction needs to be more general rather than focusing on one type of membrane receptors.

2. Figure 1: Experimental layout - the steps shall be described in details with graphical/pictorial representation of steps making it easier for the readers to follow.

3. Authors should incorporate the practical problems faced and troubleshooting they performed.

4. Lastly, it would be good to add a table showing the limitations and advantages of the existing techniques including the one described by the authors.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Alain COUVINEAU

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Jun 11;19(6):e0304172. doi: 10.1371/journal.pone.0304172.r002

Author response to Decision Letter 0


24 Apr 2024

We have addressed reviewers’ criticisms (in italics) as it follows:

1. Does the manuscript report a protocol which is of utility to the research community and adds value to the published literature?

Reviewer #1: Yes

Reviewer #2: Yes

We thank reviewers for appreciating the utility of our protocol and for recognizing its novelty.

2. Has the protocol been described in sufficient detail?

To answer this question, please click the link to protocols.io (DOI: dx.doi.org/10.17504/protocols.io.rm7vzj8z8lx1/v1 (Private link for reviewers: https://www.protocols.io/private/46322724FDB111EEB7ED0A58A9FEAC02 to be removed before publication.) in the Materials and Methods section of the manuscript or consult the step-by-step protocol in the Supporting Information files. The step-by-step protocol should contain sufficient detail for another researcher to be able to reproduce all experiments and analyses.

Reviewer #1: Partly

Reviewer #2: Yes

Following the Editor suggestion the step-by-step protocol, included in Supporting information in the previous version, was included and published into protocols.io . Please see:

Please see DOI: dx.doi.org/10.17504/protocols.io.rm7vzj8z8lx1/v1 (Private link for reviewers: https://www.protocols.io/private/46322724FDB111EEB7ED0A58A9FEAC02 to be removed before publication.)

3. Does the protocol describe a validated method?

The manuscript must demonstrate that the protocol achieves its intended purpose: either by containing appropriate validation data, or referencing at least one original research article in which the protocol was used to generate data.

Reviewer #1: Yes

Reviewer #2: Yes

Here we described immobilized VEGF-A-recruited receptor to demonstrate the cogency of our method. The method allowed us to compare different experimental conditions such as different stimuli, inhibitors, receptors mutants and multiple receptors and co-receptors at the same time (see Damioli et al.).

4. If the manuscript contains new data, have the authors made this data fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: N/A

Reviewer #2: Yes

We added statistic detail s in figure captions.

5. Is the article presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please highlight any specific errors that need correcting in the box below.

Reviewer #1: Yes

Reviewer #2: Yes

The typos and grammar errors were corrected.

Reviewer Comments to the Author:

Reviewer #1

The proposed manuscript by R. Cosetta and al. is dedicated to the development of a new approach to determine the receptor dynamics in the cell membrane. This approach was developed to use technology easily available in most research centers. This technological manuscript well describes the interest of such approach.

However, some important points should be addressed to improve this manuscript:

- The authors indicated that this approach was "...an economical and simple assay to follow and characterize membrane receptor dynamics..." and that the use of epifluorescence microscopy (EM) was possible. However, in their descriptions, the authors used confocal microscopy and some related techniques such as image stacking (not really accessible in EM). The authors should describe the use of EM in this approach.

Working in Z-stack and quantifying fluorescence in each slice, it is important to have a good 3D sectioning. We achieved it using structured illumination technology which is less expensive and time-consuming than a confocal laser microscopy. Alternatively a deconvolution algorithm ( plugins for Fiji or DeconvolutionLab and DeconvolutionLab2 (EPFL) (https://bigwww.epfl.ch/deconvolution/) can be used to analyze fluorescent stack image series . See lines 196-202 and Table 1

- The number of cells analyzed was not reported. The number of experiments was also not reported. These items should be reported.

We apologize for forgetting to include the number of analyzed cells in each experiment and the number of experiments carried out. For each experiment, repeated three times, 20 cells were analyzed at each time point. We added this information in the Expected Results section (see linse 161-162).

- How was the percentage of positive areas determined? Image analysis? Software used? procedure?

All the information regarding image quantification is reported in Supporting information: Step 5, Image quantification and data analysis (day 5). Briefly, for each experiment images were acquired with the same exposure time. Then, Z-stacks were analyzed with Fiji software. After defining a threshold, we drew a ROI for each cell in which we quantified the number of fluorescence-positive pixels in every slice of the Z-stack. Finally, we calculated the percentage of the receptor present in every slice to visualize its distribution.

- The authors do not discuss other methods to study receptor dynamics. This should be discussed. The advantages and limitations of this new approach should also be discussed.

We thank both Reviewers for the suggestion of deepening advantages and limitations of the methods currently available to study receptor dynamics on cell membranes. To address it, we decided to include a Table in Discussion section (Table 1, line 222) describing positive and negative aspects of the proposed protocol compared with the other two main methodologies: FRAP and SPT.

- The authors cited reference 17 for analysis of VEGFR and other receptor expression, but this reference did not use the same method. This should be discussed.

In the manuscript we refer to the papers by Damioli et al. (DOI) and Ravelli et al. (DOI) in which this protocol was used. In those publications, however, we focused our attention only on the quantification of receptors (VEGFR2 and Beta3 integrin) recruited in close contact with the immobilized factors. Here we analyzed the distribution, in time, of the entire pool of receptor.

- The authors do not indicate whether the internalization of the receptors could be detected with this method ? or not.

We added a comment on the possibility of detection receptor internalization in lines 218-222.

Reviewer #2:

The authors provide an alternative cost effective method for visualizing receptor dynamics in cell membranes. The protocol is well-described, providing clear step-by-step instructions for conducting the experiments. There are few suggestions that would help to improve the manuscript:

1. The introduction needs to be more general rather than focusing on one type of membrane receptors.

We introduced the different classes of membrane receptors in the introduction section ( see lines 32-36) , Then we focused only on one pass transmembrane receptors. Although we have no reason to think that the described protocol cannot be used to follow all kinds of receptors, we have alway applied it to analyze the dynamics of single-pass receptors ( e.i tyrosine kinase and integrins).

2. Figure 1: Experimental layout - the steps shall be described in details with graphical/pictorial representation of steps making it easier for the readers to follow.

Following the reviewer’s suggestion we included in the revised version (Fig 2) a cartoon which recapitulates the steps from the coverslip flipping to image quantification. Fig 2: Cartoon of steps 3-5 of experimental flow chart (see lines 89, 147 and Fig2).

3. Authors should incorporate the practical problems faced and troubleshooting they performed.

The practical problem and the critical steps were included into DOI: dx.doi.org/10.17504/protocols.io.rm7vzj8z8lx1/v1 (Private link for reviewers: https://www.protocols.io/private/46322724FDB111EEB7ED0A58A9FEAC02 to be removed before publication.)

4. Lastly, it would be good to add a table showing the limitations and advantages of the existing techniques including the one described by the authors.

We included limitations and advantages in Table 1 (Advantages and disadvantages of microscopy techniques for the study of molecule relocation) and described in the Discussion section of the revised version. See Table 1, line 222 .

Sincerely

Prof.ssa Stefania Mitola

Attachment

Submitted filename: rebuttal.pdf

pone.0304172.s002.pdf (320.8KB, pdf)

Decision Letter 1

Eleftherios Paschalis Ilios

8 May 2024

Alternative method to visualize receptor dynamics in cell membranes.

PONE-D-24-04439R1

Dear Dr. Mitola,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Eleftherios Paschalis Ilios

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Thank you for addressing the comments

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript report a protocol which is of utility to the research community and adds value to the published literature?

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the protocol been described in sufficient detail?

To answer this question, please click the link to protocols.io in the Materials and Methods section of the manuscript (if a link has been provided) or consult the step-by-step protocol in the Supporting Information files.

The step-by-step protocol should contain sufficient detail for another researcher to be able to reproduce all experiments and analyses.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Does the protocol describe a validated method?

The manuscript must demonstrate that the protocol achieves its intended purpose: either by containing appropriate validation data, or referencing at least one original research article in which the protocol was used to generate data.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. If the manuscript contains new data, have the authors made this data fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the article presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please highlight any specific errors that need correcting in the box below.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The proposed manuscript by R. Cosetta and al. is dedicated to the development of a

new approach to determine the receptor dynamics in the cell membrane. This

approach was developed to use technology easily available in most research centers.

This technological manuscript well describes the interest of such approach.

The authors having totally replied to my previous comments. In this context, the present manuscript should be accepter for publication.

Reviewer #2: The authors have successfullly addressed all the comments and revised the manuscript accordingly.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Alain Couvineau

Reviewer #2: Yes: Jyoti Sharma

**********

Acceptance letter

Eleftherios Paschalis Ilios

31 May 2024

PONE-D-24-04439R1

PLOS ONE

Dear Dr. Stefania,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Eleftherios Paschalis Ilios

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File

    (PDF)

    pone.0304172.s001.pdf (263.7KB, pdf)
    Attachment

    Submitted filename: rebuttal.pdf

    pone.0304172.s002.pdf (320.8KB, pdf)

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES